Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Statistics

Total Valuation

KYTX has a market cap or net worth of $475.16 million. The enterprise value is $273.08 million.

Market Cap	475.16M
Enterprise Value	273.08M

Important Dates

The last earnings date was Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

KYTX has 60.53 million shares outstanding. The number of shares has increased by 12.42% in one year.

Current Share Class	60.53M
Shares Outstanding	60.53M
Shares Change (YoY)	+12.42%
Shares Change (QoQ)	+28.16%
Owned by Insiders (%)	1.74%
Owned by Institutions (%)	39.53%
Float	35.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	951.54
PB Ratio	2.45
P/TBV Ratio	2.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.15, with a Debt / Equity ratio of 0.17.

Current Ratio	8.15
Quick Ratio	7.97
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-144.82

Financial Efficiency

Return on equity (ROE) is -74.55% and return on invested capital (ROIC) is -44.48%.

Return on Equity (ROE)	-74.55%
Return on Assets (ROA)	-39.55%
Return on Invested Capital (ROIC)	-44.48%
Return on Capital Employed (ROCE)	-72.04%
Weighted Average Cost of Capital (WACC)	14.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.20M
Employee Count	130
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +196.60% in the last 52 weeks. The beta is 1.96, so KYTX's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	+196.60%
50-Day Moving Average	9.03
200-Day Moving Average	7.63
Relative Strength Index (RSI)	36.81
Average Volume (20 Days)	872,907

Short Selling Information

The latest short interest is 5.28 million, so 8.73% of the outstanding shares have been sold short.

Short Interest	5.28M
Short Previous Month	5.16M
Short % of Shares Out	8.73%
Short % of Float	14.95%
Short Ratio (days to cover)	4.13

Income Statement

Revenue	n/a
Gross Profit	-126.36M
Operating Income	-163.79M
Pretax Income	-156.40M
Net Income	-156.40M
EBITDA	-162.14M
EBIT	-163.79M
Earnings Per Share (EPS)	-$3.23

Balance Sheet

The company has $236.45 million in cash and $33.76 million in debt, with a net cash position of $202.69 million or $3.35 per share.

Cash & Cash Equivalents	236.45M
Total Debt	33.76M
Net Cash	202.69M
Net Cash Per Share	$3.35
Equity (Book Value)	195.58M
Book Value Per Share	3.23
Working Capital	212.05M

Cash Flow

In the last 12 months, operating cash flow was -$150.39 million and capital expenditures -$5,000, giving a free cash flow of -$150.40 million.

Operating Cash Flow	-150.39M
Capital Expenditures	-5,000
Depreciation & Amortization	1.65M
Net Borrowing	24.15M
Free Cash Flow	-150.40M
FCF Per Share	-$2.48

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.42%
Shareholder Yield	-12.42%
Earnings Yield	-32.87%
FCF Yield	-31.61%

Analyst Forecast

The average price target for KYTX is $30.40, which is 287.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.40
Price Target Difference	287.26%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2